Comments: US HB6227 | 2023-2024 | 118th Congress

Bill Title: Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023

Spectrum: Bipartisan Bill

Status: (Introduced) 2023-11-10 - Referred to the Subcommittee on Health. [HB6227 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2023 US Congress HB6227 at this time.

Social Comments on US HB6227

feedback